Tirzepatide 10mg
Tirzepatide is a synthetic analogue of gastric inhibitory polypeptide (GIP) designed to stimulate insulin release, addressing both type 2 diabetes and non-alcoholic fatty liver disease. Comprising 39 amino acids, this peptide binds to both GIP and GLP-1 receptors, effectively lowering blood glucose levels, increasing insulin sensitivity, and promoting weight loss.
Tirzepatide is a synthetic analogue of gastric inhibitory polypeptide (GIP) designed to stimulate insulin release, addressing both type 2 diabetes and non-alcoholic fatty liver disease. Comprising 39 amino acids, this peptide binds to both GIP and GLP-1 receptors, effectively lowering blood glucose levels, increasing insulin sensitivity, and promoting weight loss.
Tirzepatide is a synthetic analogue of gastric inhibitory polypeptide (GIP) designed to stimulate insulin release, addressing both type 2 diabetes and non-alcoholic fatty liver disease. Comprising 39 amino acids, this peptide binds to both GIP and GLP-1 receptors, effectively lowering blood glucose levels, increasing insulin sensitivity, and promoting weight loss.
Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.
What is Tirzepatide?
Tirzepatide is a unique peptide that combines the functionalities of GIP and GLP-1, making it a powerful agent in managing type 2 diabetes and promoting weight loss. By stimulating insulin release from the pancreas, it effectively lowers blood glucose levels and improves insulin sensitivity. Additionally, it boosts adiponectin levels, reduces hunger, and increases feelings of satiety.
Key Functions and Benefits
Blood Glucose Regulation: Lowers blood glucose levels by stimulating insulin release and enhancing insulin sensitivity.
Weight Loss: Promotes significant weight loss by reducing hunger, increasing satiety, and decreasing adipose tissue.
Cardiovascular Protection: Reduces cardiovascular risk by improving glucose tolerance and metabolic health.
Adiponectin Increase: Elevates adiponectin levels by up to 26%, contributing to improved metabolic health.
Mechanisms of Action
Tirzepatide’s primary mechanisms of action include:
Dual Receptor Binding: Binds to both GIP and GLP-1 receptors, stimulating insulin release and enhancing insulin sensitivity.
Appetite Regulation: Reduces feelings of hunger and increases satiety, leading to decreased food intake and weight loss.
Metabolic Improvement: Lowers insulin levels, increases glucose tolerance, and reduces fat tissue.
Unique Characteristics
Tirzepatide's dual action on GIP and GLP-1 receptors makes it a versatile and powerful peptide for managing type 2 diabetes and promoting weight loss. Its ability to improve cardiovascular health and metabolic parameters highlights its potential for broader therapeutic applications.
Tirzepatide Peptide Structure
Sequence: YE-Aib-GTFTSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS Note: Aib is a non-coded (non-proteinogenic) amino acid - H2H-C(CH3)2-COOH
Molecular Formula: C225H348N48O68
Molecular Weight: 4813.52 g/mol
PubChem CID: 156588324
CAS Number: 2023788-19-2
Synonyms: P1206, LY3298176
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.